Pharmaceutical manufacturing

March 12, 2019 - 3:58 am
MINNETONKA, Minn. (AP) — The nation's largest health insurer is expanding a program that passes rebates from drugmakers directly to the people that use their medications. Beginning next year, all employer-sponsored health care plans that use UnitedHealthcare must give point-of-sale discounts...
Read More
FILE- This April 26, 2017, file photo shows the Eli Lilly and Co. corporate headquarters in Indianapolis. Eli Lilly is offering a half-price version of its top-selling insulin Humalog as drugmakers face growing pressure to control prices. The drugmaker says it will introduce a version of the diabetes treatment called Insulin Lispro with a list price 50 percent lower than its current rate, about $275 per vial. (AP Photo/Darron Cummings, File)
March 04, 2019 - 11:32 am
INDIANAPOLIS (AP) — Eli Lilly is offering a half-price version of a top-selling insulin to ease the financial strain imposed on some patients, but an advocacy group says much bigger changes are needed. The drugmaker said Monday it will introduce a version of the diabetes treatment Humalog that will...
Read More
February 27, 2019 - 1:57 am
COPENHAGEN, Denmark (AP) — Volatility in stock markets last year pushed Norway's sovereign wealth fund, the world's largest of its kind, to report a loss of 485 billion kroner ($56.4 billion) for 2018. Fund manager Norges Bank Investment Management says the fund's worst-performing investments in...
Read More
From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson, Kenneth C. Frazier, Chairman and Chief Executive Officer Merck & Co., Inc., Albert Bourla, DVM, Ph.D. Chief Executive Office Pfizer, Olivier Brandicourt, M.D. Chief Executive Officer Sanofi, prepare to testify before the Senate Finance Committee hearing on drug prices, Tuesday, Feb. 26, 2019 on Capitol Hill in Washington. (AP Photo/Pablo Martinez Monsivais)
February 26, 2019 - 1:03 pm
WASHINGTON (AP) — Channeling the ire of constituents and drawing from personal experience, senators chastised drug company executives Tuesday over the high cost of prescription medications, while the CEOs warned that government price controls could stifle breakthroughs on diseases like Alzheimer's...
Read More
From l-r., Richard A. Gonzalez , Chairman and Chief Executive Officer AbbVie Inc., Pascal Soriot, Executive Director and Chief Executive Officer AstraZeneca, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson, Kenneth C. Frazier, Chairman and Chief Executive Officer Merck & Co., Inc., Albert Bourla, DVM, Ph.D. Chief Executive Office Pfizer, Olivier Brandicourt, M.D. Chief Executive Officer Sanofi, wait to testify before the Senate Finance Committee hearing on drug prices, Tuesday, Feb. 26, 2019 on Capitol Hill in Washington. (AP Photo/Pablo Martinez Monsivais)
February 26, 2019 - 9:41 am
WASHINGTON (AP) — The Latest on top pharmaceutical executives testifying before Senate lawmakers on rising drug prices (all times local): 12:40 p.m. Seven top pharmaceutical executives are telling lawmakers they do not withhold their drugs from potential competitors to stop them from developing...
Read More
February 25, 2019 - 11:40 am
Stocks marched higher on Wall Street Monday after President Donald Trump agreed to hold off on raising tariffs on Chinese goods, which would have escalated a damaging trade war between the world's two largest economies. Investors had been growing increasingly optimistic over the last two weeks that...
Read More
February 24, 2019 - 1:43 pm
WASHINGTON (AP) — With health care a top issue for American voters, Congress may actually be moving toward doing something this year to address the high cost of prescription drugs. President Donald Trump, Democrats trying to retire him in 2020, and congressional incumbents of both parties all say...
Read More
FILE- In this Aug. 7, 2018, file photo a CVS Pharmacy building sign rests on a Jackson, Miss., store. CVS Health topped fourth-quarter earnings forecasts, but the nation’s second-largest drugstore chain also debuted a 2019 outlook that fell far short of Wall Street expectations. The company said Wednesday, Feb. 20, 2019, that it expects adjusted earnings to range between $6.68 and $6.88 this year. FactSet says analysts expect earnings of $7.35 per share. (AP Photo/Rogelio V. Solis, File)
February 20, 2019 - 6:15 am
CVS Health beat fourth-quarter earnings forecasts, but a struggling long-term care business took another huge bite out of the company's performance and its initial 2019 forecast was weaker than expected. Shares tumbled nearly 9 percent before the opening bell Wednesday. CEO Larry Merlo said in a...
Read More
This undated product image provided by Janssen Pharmaceuticals, Inc. shows Xarelto. Johnson & Johnson says it will start giving the list price of its prescription drugs in television ads. The company would be the first drugmaker to take that step. J&J said Thursday, Feb. 7, 2019, it would start with its popular blood thinner, Xarelto. (Janssen Pharmaceuticals, Inc. via AP)
February 07, 2019 - 11:26 am
TRENTON, N.J. (AP) — Johnson & Johnson said Thursday it will start giving the list price of its prescription drugs in television ads. The company would be the first drugmaker to take that step. The health care giant will begin with its popular blood thinner, Xarelto, said Scott White, head of J...
Read More
FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
February 01, 2019 - 5:10 pm
WASHINGTON (AP) — The Trump administration's top health official asked Congress on Friday to pass its new prescription drug discount plan and provide it to all patients, not just those covered by government programs like Medicare. The plan would take now-hidden rebates among industry players like...
Read More

Pages